Roll-out of affordable malaria vaccine begins
R21 is approved for babies and may save hundreds of thousands of lives
![Vials of the R21 Malaria Vaccine](https://cdn.mos.cms.futurecdn.net/PnDwLabXLBJzLvMpP3n5Km-415-80.jpg)
What happened
Babies in the Ivory Coast and South Sudan will begin receiving doses of the world's first affordable malaria vaccine from today. R21, approved for children under three, costs around $4 a dose and is up to 79% effective at preventing the disease.
Who said what
"A malaria-free world is finally within sight," Adar Poonawalla, the chief executive of India-based manufacturer the Serum Institute, said to The Times. "It's been long awaited, but here we finally are," said Adrian Hill, the director of the Jenner Institute at Oxford University, who has been working on malaria vaccines for 30 years.
R21 has a "huge advantage" over the only other malaria jab, said The Times. RTS,S, developed by British drug-maker GlaxoSmithKline, is more than twice as expensive and manufacturing capacity is limited to six million doses a year, compared with 100 million for R21.
What next?
Fifteen African countries will have introduced the R21 vaccine by the end of the year, with another 15 due to follow. Trials for pregnant women will start in the coming weeks.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
![https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg](https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516-320-80.jpg)
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Arion McNicoll is a freelance writer at The Week Digital and was previously the UK website’s editor. He has also held senior editorial roles at CNN, The Times and The Sunday Times. Along with his writing work, he co-hosts “Today in History with The Retrospectors”, Rethink Audio’s flagship daily podcast, and is a regular panellist (and occasional stand-in host) on “The Week Unwrapped”. He is also a judge for The Publisher Podcast Awards.
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Brief Canada rail lockout ends with arbitration
Speed Read A prolonged shutdown could have threatened the country's supply chain
By Rafi Schwartz, The Week US Published
-
In DNC finale, Harris asks America to turn the page
Speed Read Vice President Kamala Harris accepted the Democratic presidential nomination with a historic speech
By Peter Weber, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
The battle for abortion buffer zones
The Explainer A 2023 law banning protests around clinics remains unenforced amid dispute over 'silent prayer'
By Harriet Marsden, The Week UK Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
WHO declares mpox a global health emergency
Speed Read An outbreak of the viral disease formerly known as monkeypox continues to spread in Africa
By Rafi Schwartz, The Week US Published
-
Why gonorrhoea is becoming 'untreatable'
In the Spotlight Infections hit record high as experts warn about rise in antibiotic-resistant cases
By Elizabeth Carr-Ellis, The Week UK Published
-
Where does MDMA-assisted therapy go from here?
Today's Big Question Psychedelic treatments face a challenge from the FDA
By Joel Mathis, The Week US Published
-
Can dementia be defeated?
Today's Big Question A new report identifies 14 risk factors
By Joel Mathis, The Week US Published
-
Deadly 'brain-eating' amoebas could be spreading thanks to climate change
Under the Radar Naegleria fowleri causes rare and lethal infection, but recent uptick in cases suggests it is thriving in warming waters
By Harriet Marsden, The Week UK Last updated